Apple, Inc AAPL
S&P 500 ETF Trust SPDR SPY
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

Zhengye Biotechnology Holding Limited Ordinary Shares, Common Stock

ZYBT

NAQ

$8.18

-$0.62

(-7.05%)

Industry: Pharmaceuticals Sector: Health Care

Analyst Forecast

Overview Returns Financials Ratios News FAQs

Price Chart

Key Metrics

Market Cap

This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.

$461.12M

P/E Ratio

This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.

83.1667

Volume

This is the total number of shares traded during the most recent trading day.

736.78K

Avg Volume

This is the average number of shares traded during the most recent 30 days.

Dividend Yield

This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).

0.00%

Beta

This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.

52-week Range
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

$3.5 L

$14.3 H

$8.18

About Zhengye Biotechnology Holding Limited Ordinary Shares, Common Stock

Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in China. It offers vaccines for swine, cattle, goats, sheep, poultry, and dogs. The company also exports its products to Vietnam, Pakistan, and Egypt. The company was founded in 2004 and is based in Jilin, China. Zhengye Biotechnology Holding Limited operates as a subsidiary of Securingium Holding Limited. more

Industry: PharmaceuticalsSector: Health Care

Returns

Time Frame	ZYBT	Sector	S&P500
1-Week Return	-15.93%	0.71%	0.79%
1-Month Return	-12.42%	-5.6%	6.04%
3-Month Return	94.3%	-11.72%	-1.11%
6-Month Return	68.31%	-10.81%	-2.39%

Time Frame	ZYBT	Sector	S&P500
1-Week Return	-99.99%	44.62%	50.73%
1-Month Return	-80.08%	-50.40%	104.12%
3-Month Return	1,378.83%	-39.68%	-4.43%
6-Month Return	187.41%	-20.70%	-4.79%

Financials

	Dec '21	Dec '22	Dec '23
Total Revenue	214.07M	260.27M	211.65M	[{"date":"2021-12-31","value":82.25,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":81.32,"profit":true}]
Cost of Revenue	88.67M	106.75M	81.80M	[{"date":"2021-12-31","value":83.07,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":76.62,"profit":true}]
Gross Profit	125.39M	153.52M	129.85M	[{"date":"2021-12-31","value":81.68,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":84.59,"profit":true}]
Gross Margin	58.58%	58.98%	61.35%	[{"date":"2021-12-31","value":95.47,"profit":true},{"date":"2022-12-31","value":96.14,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Operating Expenses	73.01M	87.69M	84.87M	[{"date":"2021-12-31","value":83.26,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":96.79,"profit":true}]
Operating Income	52.38M	65.83M	44.99M	[{"date":"2021-12-31","value":79.57,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":68.33,"profit":true}]
Total Non-Operating Income/Expense	(251.00K)	(4.64M)	(5.33M)	[{"date":"2021-12-31","value":-25100000,"profit":false},{"date":"2022-12-31","value":-464500000,"profit":false},{"date":"2023-12-31","value":-533500000,"profit":false}]
Pre-Tax Income	53.07M	63.91M	43.76M	[{"date":"2021-12-31","value":83.03,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":68.47,"profit":true}]
Income Taxes	6.60M	8.17M	6.25M	[{"date":"2021-12-31","value":80.75,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":76.52,"profit":true}]
Income After Taxes	46.47M	55.74M	37.51M	[{"date":"2021-12-31","value":83.36,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":67.29,"profit":true}]

Income From Continuous Operations	46.47M	55.74M	37.51M	[{"date":"2021-12-31","value":83.36,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":67.29,"profit":true}]
Income From Discontinued Operations	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income	38.96M	46.73M	31.46M	[{"date":"2021-12-31","value":83.36,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":67.31,"profit":true}]

EPS (Diluted)	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

	Dec '21	Dec '22	Dec '23
Total Revenue	-	21.58%	(18.68%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-86.55,"profit":false}]
Cost of Revenue	-	20.38%	(23.38%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-114.67,"profit":false}]
Gross Profit	-	22.43%	(15.41%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-68.72,"profit":false}]
Gross Margin	-	0.70%	4.02%	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":17.35,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Operating Expenses	-	20.10%	(3.21%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-15.98,"profit":false}]
Operating Income	-	25.68%	(31.67%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-123.32,"profit":false}]
Total Non-Operating Income/Expense	-	1750.60%	14.85%	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":0.85,"profit":true}]
Pre-Tax Income	-	20.44%	(31.53%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-154.24,"profit":false}]
Income Taxes	-	23.84%	(23.48%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-98.51,"profit":false}]
Income After Taxes	-	19.96%	(32.71%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-163.87,"profit":false}]

Income From Continuous Operations	-	19.96%	(32.71%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-163.87,"profit":false}]
Income From Discontinued Operations	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income	-	19.96%	(32.69%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-163.79,"profit":false}]

EPS (Diluted)	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]


Total Revenue	[]
Cost of Revenue	[]
Gross Profit	[]
Gross Margin	[]

Operating Expenses	[]
Operating Income	[]
Total Non-Operating Income/Expense	[]
Pre-Tax Income	[]
Income Taxes	[]
Income After Taxes	[]

Income From Continuous Operations	[]
Income From Discontinued Operations	[]
Net Income	[]

EPS (Diluted)	[]


Total Revenue	[]
Cost of Revenue	[]
Gross Profit	[]
Gross Margin	[]

Operating Expenses	[]
Operating Income	[]
Total Non-Operating Income/Expense	[]
Pre-Tax Income	[]
Income Taxes	[]
Income After Taxes	[]

Income From Continuous Operations	[]
Income From Discontinued Operations	[]
Net Income	[]

EPS (Diluted)	[]

	Dec '21	Dec '22	Dec '23
Total Assets
Current Assets	164.94M	214.31M	205.59M	[{"date":"2021-12-31","value":76.97,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":95.93,"profit":true}]
Non-current Assets	280.33M	305.37M	294.30M	[{"date":"2021-12-31","value":91.8,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":96.37,"profit":true}]
Total Assets	445.28M	519.67M	499.89M	[{"date":"2021-12-31","value":85.68,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":96.19,"profit":true}]

Total Liabilities
Current Liabilities	125.63M	152.23M	150.23M	[{"date":"2021-12-31","value":82.53,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":98.69,"profit":true}]
Non-current Liabilities	816.00K	10.58M	10.38M	[{"date":"2021-12-31","value":7.71,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":98.14,"profit":true}]
Total Liabilities	126.44M	162.81M	160.62M	[{"date":"2021-12-31","value":77.66,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":98.65,"profit":true}]

Total Shareholders' equity
Common Stock	8.00K	8.00K	8.00K	[{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Retained Earnings	42.33M	65.77M	38.38M	[{"date":"2021-12-31","value":64.35,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":58.35,"profit":true}]
Other Stockholders' Equity	203.15M	203.15M	203.15M	[{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Total Shareholders' equity	267.47M	296.50M	272.85M	[{"date":"2021-12-31","value":90.21,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":92.02,"profit":true}]

Total Liabilities & Shareholders Equity	393.92M	459.30M	433.47M	[{"date":"2021-12-31","value":85.76,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":94.37,"profit":true}]

	Dec '21	Dec '22	Dec '23
Total Assets
Current Assets	-	29.93%	(4.07%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-13.59,"profit":false}]
Non-current Assets	-	8.93%	(3.63%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-40.6,"profit":false}]
Total Assets	-	16.71%	(3.81%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-22.79,"profit":false}]

Total Liabilities
Current Liabilities	-	21.17%	(1.31%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-6.19,"profit":false}]
Non-current Liabilities	-	1196.57%	(1.86%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-0.16,"profit":false}]
Total Liabilities	-	28.76%	(1.35%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-4.68,"profit":false}]

Total Shareholders' equity
Common Stock	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Retained Earnings	-	55.40%	(41.65%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-75.17,"profit":false}]
Other Stockholders' Equity	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Total Shareholders' equity	-	10.85%	(7.98%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-73.5,"profit":false}]

Total Liabilities & Shareholders Equity	-	16.60%	(5.63%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-33.89,"profit":false}]

	Dec '22	Jun '23	Dec '23
Total Assets
Current Assets	214.31M	216.92M	205.59M	[{"date":"2022-12-31","value":98.8,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-12-31","value":94.78,"profit":true}]
Non-current Assets	305.37M	296.91M	294.30M	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-06-30","value":97.23,"profit":true},{"date":"2023-12-31","value":96.37,"profit":true}]
Total Assets	519.67M	513.83M	499.89M	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-06-30","value":98.88,"profit":true},{"date":"2023-12-31","value":96.19,"profit":true}]

Total Liabilities
Current Liabilities	152.23M	177.42M	150.23M	[{"date":"2022-12-31","value":85.8,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-12-31","value":84.68,"profit":true}]
Non-current Liabilities	10.58M	10.58M	10.38M	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-12-31","value":98.14,"profit":true}]
Total Liabilities	162.81M	188.00M	160.62M	[{"date":"2022-12-31","value":86.6,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-12-31","value":85.44,"profit":true}]

Total Shareholders' equity
Common Stock	8.00K	8.00K	8.00K	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Retained Earnings	65.77M	30.85M	38.38M	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-06-30","value":46.9,"profit":true},{"date":"2023-12-31","value":58.35,"profit":true}]
Other Stockholders' Equity	203.15M	203.15M	203.15M	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Total Shareholders' equity	296.50M	261.57M	272.85M	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-06-30","value":88.22,"profit":true},{"date":"2023-12-31","value":92.02,"profit":true}]

Total Liabilities & Shareholders Equity	459.30M	449.57M	433.47M	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-06-30","value":97.88,"profit":true},{"date":"2023-12-31","value":94.37,"profit":true}]

	Dec '22	Jun '23	Dec '23
Total Assets
Current Assets	-	-	(5.22%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]
Non-current Assets	-	-	(0.88%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]
Total Assets	-	-	(2.71%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]

Total Liabilities
Current Liabilities	-	-	(15.32%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]
Non-current Liabilities	-	-	(1.86%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]
Total Liabilities	-	-	(14.56%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]

Total Shareholders' equity
Common Stock	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Retained Earnings	-	-	24.41%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Other Stockholders' Equity	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Total Shareholders' equity	-	-	4.31%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Total Liabilities & Shareholders Equity	-	-	(3.58%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]

	Dec '21	Dec '22	Dec '23
Operating Activities
Net Operating Cash Flow	31.81M	17.34M	48.18M	[{"date":"2021-12-31","value":66.01,"profit":true},{"date":"2022-12-31","value":35.98,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Investing Activities
Net Investing Cash Flow	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	(3.05M)	13.46M	(18.98M)	[{"date":"2021-12-31","value":-22.65,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-141.06,"profit":false}]

Net Change in Cash	2.49M	3.46M	17.44M	[{"date":"2021-12-31","value":14.27,"profit":true},{"date":"2022-12-31","value":19.85,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Free Cash Flow
Free Cash Flow	5.41M	(9.99M)	36.58M	[{"date":"2021-12-31","value":14.79,"profit":true},{"date":"2022-12-31","value":-27.32,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]

	Dec '21	Dec '22	Dec '23
Operating Activities
Net Operating Cash Flow	-	(45.50%)	177.96%	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-25.57,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]

Investing Activities
Net Investing Cash Flow	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	-	(541.44%)	(241.06%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false}]

Net Change in Cash	-	39.09%	403.76%	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":9.68,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Free Cash Flow
Free Cash Flow	-	(284.75%)	(466.10%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

	ZYBT
Cash Ratio	0.11
Current Ratio	1.37
Quick Ratio	0.98

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

	ZYBT
ROA (LTM)	3.82%
ROE (LTM)	7.15%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

	ZYBT
Debt Ratio Lower is generally better. Negative is bad.	0.32
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier.	0.55

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

	ZYBT
Trailing PE	83.17
Forward PE	NM
P/S (TTM)	1.24
P/B	6.11
EV/R	9.48
EV/Ebitda	31.36

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

FAQs

What is Zhengye Biotechnology Holding Limited Ordinary Shares share price today?

Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) share price today is $8.18

Can Indians buy Zhengye Biotechnology Holding Limited Ordinary Shares shares?

Yes, Indians can buy shares of Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) on Vested. To buy Zhengye Biotechnology Holding Limited Ordinary Shares from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in ZYBT stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Zhengye Biotechnology Holding Limited Ordinary Shares be purchased?

Yes, you can purchase fractional shares of Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) via the Vested app. You can start investing in Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) with a minimum investment of $1.

How to invest in Zhengye Biotechnology Holding Limited Ordinary Shares shares from India?

You can invest in shares of Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) via Vested in three simple steps:

Click on Sign Up or Invest in ZYBT stock at the top of this page
Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
Transfer USD funds to your US Brokerage account and start investing in Zhengye Biotechnology Holding Limited Ordinary Shares shares

What is Zhengye Biotechnology Holding Limited Ordinary Shares 52-week high and low stock price?

The 52-week high price of Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) is $14.3. The 52-week low price of Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) is $3.5.

What is Zhengye Biotechnology Holding Limited Ordinary Shares price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) is 83.1667

What is Zhengye Biotechnology Holding Limited Ordinary Shares price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) is 6.11

What is the Market Cap of Zhengye Biotechnology Holding Limited Ordinary Shares?

The market capitalization of Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) is $461.12M

What is Zhengye Biotechnology Holding Limited Ordinary Shares’s stock symbol?

The stock symbol (or ticker) of Zhengye Biotechnology Holding Limited Ordinary Shares is ZYBT